MedTrace Logo

Effects on the Patellar Tendon After Low-load Blood Flow Restriction Training.

NCT05538494 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2022-09-14

No results posted yet for this study

Summary

The main objective of this research project is to study the transient adaptations that occur in the tendon immediately after the object of training with low loads and blood flow restriction and to compare these adaptations with those derived from training with high loads, in order to thus helping to elucidate the complex existing framework regarding the effects of this training methodology on the tendon.

Conditions

  • Patellar Tendinitis

Interventions

OTHER

BFR intervention

Training is applied to this group using low-load exercises with restriction of blood flow. Based on the variables used by the major part of the protocols used in studies on the ERFS, the protocol that will be applied to this group will consist of the following parameters. * Training: 1 series of 30 repetitions followed by 3 series of 15 repetitions of squats * Rest between series: Duration of 45 seconds. * Workload: 30% of 1RM. * Cadence: 2 seconds for the concentric phase and 2 seconds for the eccentric phase (2:2). * Cuff pressure: The inflation pressure will be individualized for each individual. A pressure equivalent to 80% of the minimum pressure necessary for the total occlusion of the femoral artery. • Cuff placement: proximal quadriceps.

OTHER

High load intervention

A program will be applied to this group of exercise with high loads as a method of treatment in which the following will be applied parameters: * Training: 4 series of 12 repetitions of squats. * Rest between series: Duration 2 minutes. * Workload: 70% of 1RM.

Sponsors & Collaborators

  • University of Alcala

    lead OTHER

Principal Investigators

  • Néstro Ruíz Alberto, Physio · University of Alcala

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-20
Primary Completion
2022-06-13
Completion
2022-09-10

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538494 on ClinicalTrials.gov